Published in J Immunol on October 15, 2006
T cell receptor-like recognition of tumor in vivo by synthetic antibody fragment. PLoS One (2012) 1.05
CD4+ T cells play a critical role in the generation of primary and memory antitumor immune responses elicited by SA-4-1BBL and TAA-based vaccines in mouse tumor models. PLoS One (2013) 0.93
TCR-like biomolecules target peptide/MHC Class I complexes on the surface of infected and cancerous cells. Int Rev Immunol (2011) 0.87
Interferon-gamma-dependent infiltration of human T cells into neuroblastoma tumors in vivo. Clin Cancer Res (2009) 0.84
A novel vascular targeting strategy for brain-derived endothelial cells using a TCR mimic antibody. J Cell Physiol (2010) 0.81
Expanding the targets available to therapeutic antibodies via novel disease-specific markers. Int Rev Immunol (2011) 0.75
Establishment of specific cytotoxic T lymphocyte culture system and its inhibitory effect on ovarian cancer. Oncol Lett (2016) 0.75
Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late. J Immunol (2016) 0.75
The physiological role of mitochondrial calcium revealed by mice lacking the mitochondrial calcium uniporter. Nat Cell Biol (2013) 3.39
Fat tissue, aging, and cellular senescence. Aging Cell (2010) 3.34
Retracted Foxp3-positive macrophages display immunosuppressive properties and promote tumor growth. J Exp Med (2011) 3.15
Recognition of lyso-phospholipids by human natural killer T lymphocytes. PLoS Biol (2009) 2.24
Definition of the viral targets of protective HIV-1-specific T cell responses. J Transl Med (2011) 1.73
Expression of sperm protein 17 (Sp17) in ovarian cancer. Int J Cancer (2004) 1.70
High accumulation of T regulatory cells prevents the activation of immune responses in aged animals. J Immunol (2006) 1.65
A high degree of HLA disparity arises from limited allelic diversity: analysis of 1775 unrelated bone marrow transplant donor-recipient pairs. Hum Immunol (2006) 1.58
Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity. J Immunol (2009) 1.57
Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity. AIDS (2012) 1.54
Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses. Infect Immun (2004) 1.49
Toward a definition of self: proteomic evaluation of the class I peptide repertoire. J Immunol (2004) 1.33
Design, synthesis, and evaluation of radiolabeled integrin alpha v beta 3 receptor antagonists for tumor imaging and radiotherapy. Cancer Biother Radiopharm (2003) 1.29
Development and validation of a fluorescence polarization-based competitive peptide-binding assay for HLA-A*0201--a new tool for epitope discovery. Biochemistry (2005) 1.26
Blockade of CCL1 inhibits T regulatory cell suppressive function enhancing tumor immunity without affecting T effector responses. J Immunol (2010) 1.21
Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infection. J Immunol (2010) 1.18
Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopes. Proc Natl Acad Sci U S A (2008) 1.18
TCR mimic monoclonal antibody targets a specific peptide/HLA class I complex and significantly impedes tumor growth in vivo using breast cancer models. J Immunol (2010) 1.18
Cutting edge: class I presentation of host peptides following HIV infection. J Immunol (2003) 1.18
The high frequency Indian rhesus macaque MHC class I molecule, Mamu-B*01, does not appear to be involved in CD8+ T lymphocyte responses to SIVmac239. J Immunol (2005) 1.17
S-nitrosylation: a radical way to protect the heart. J Mol Cell Cardiol (2011) 1.16
Nanotechnology and human health: risks and benefits. J Appl Toxicol (2010) 1.15
AKAP-4: a novel cancer testis antigen for multiple myeloma. Br J Haematol (2008) 1.11
Protein kinase C-epsilon coimmunoprecipitates with cytochrome oxidase subunit IV and is associated with improved cytochrome-c oxidase activity and cardioprotection. Am J Physiol Heart Circ Physiol (2007) 1.11
HLA class I molecules consistently present internal influenza epitopes. Proc Natl Acad Sci U S A (2009) 1.07
Cancer testis antigens: novel biomarkers and targetable proteins for ovarian cancer. Int Rev Immunol (2011) 1.06
Systemic targeting of CpG-ODN to the tumor microenvironment with anti-neu-CpG hybrid molecule and T regulatory cell depletion induces memory responses in BALB-neuT tolerant mice. Cancer Res (2008) 1.06
Disruption of caveolae blocks ischemic preconditioning-mediated S-nitrosylation of mitochondrial proteins. Antioxid Redox Signal (2011) 1.05
Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma. J Transl Med (2007) 1.05
Maximal T cell-mediated antitumor responses rely upon CCR5 expression in both CD4(+) and CD8(+) T cells. Cancer Res (2011) 1.05
Aging affect the anti-tumor potential of dendritic cell vaccination, but it can be overcome by co-stimulation with anti-OX40 or anti-4-1BB. Exp Gerontol (2005) 1.04
Identification of breast cancer peptide epitopes presented by HLA-A*0201. J Proteome Res (2008) 1.04
Real-time measurement of in vitro peptide binding to soluble HLA-A*0201 by fluorescence polarization. Biochemistry (2004) 1.03
Signals through 4-1BB inhibit T regulatory cells by blocking IL-9 production enhancing antitumor responses. Cancer Immunol Immunother (2011) 1.03
Cancer: looking for simplicity and finding complexity. Cancer Cell Int (2006) 1.01
The cap binding complex influences H2B ubiquitination by facilitating splicing of the SUS1 pre-mRNA. RNA (2009) 1.01
T-cell tolerance for variability in an HLA class I-presented influenza A virus epitope. J Virol (2009) 1.00
Vaccination with dendritic cells pulsed with apoptotic tumors in combination with anti-OX40 and anti-4-1BB monoclonal antibodies induces T cell-mediated protective immunity in Her-2/neu transgenic mice. Int J Cancer (2005) 1.00
A charged amino acid residue in the transmembrane/cytoplasmic region of tapasin influences MHC class I assembly and maturation. J Immunol (2005) 1.00
Identification of an HLA A*0201-restricted CD8(+) T-cell epitope for the glycoprotein B homolog of human herpesvirus 8. Blood (2002) 0.99
Gene expression and immunologic consequence of SPAN-Xb in myeloma and other hematologic malignancies. Blood (2002) 0.98
Sperm protein 17 is expressed in human somatic ciliated epithelia. J Histochem Cytochem (2004) 0.96
The complexity of anatomical systems. Theor Biol Med Model (2005) 0.96
Antibody targeting to a class I MHC-peptide epitope promotes tumor cell death. J Immunol (2006) 0.96
Production of monoclonal antibodies. Curr Protoc Immunol (2013) 0.95
Structure-activity relationships of 111In- and 99mTc-labeled quinolin-4-one peptidomimetics as ligands for the vitronectin receptor: potential tumor imaging agents. Bioconjug Chem (2006) 0.95
Differential MHC class I expression in distinct leukocyte subsets. BMC Immunol (2011) 0.94
Markov model recognition and classification of DNA/protein sequences within large text databases. Bioinformatics (2005) 0.94
Processing and presentation of exogenous HLA class I peptides by dendritic cells from human immunodeficiency virus type 1-infected persons. J Virol (2005) 0.94
HLA antigens, alleles and haplotypes among the Yup'ik Alaska natives: report of the ASHI Minority Workshops, Part II. Hum Immunol (2002) 0.93
Notch1 regulates chemotaxis and proliferation by controlling the CC-chemokine receptors 5 and 9 in T cell acute lymphoblastic leukaemia. J Pathol (2011) 0.93
Differential loss of cytochrome-c oxidase subunits in ischemia-reperfusion injury: exacerbation of COI subunit loss by PKC-epsilon inhibition. Am J Physiol Heart Circ Physiol (2008) 0.93
Sperm protein 17 is expressed in human nervous system tumours. BMC Cancer (2006) 0.93
A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting. Immunol Rev (2008) 0.92
Quantitative evaluation and modeling of two-dimensional neovascular network complexity: the surface fractal dimension. BMC Cancer (2005) 0.92
HLA class I molecules reflect an altered host proteome after influenza virus infection. Hum Immunol (2010) 0.92
CpG-ODN but not other TLR-ligands restore the antitumor responses in old mice: the implications for vaccinations in the aged. Cancer Immunol Immunother (2007) 0.92
Evaluating Parkinson's disease patients at home: utility of self-videotaping for objective motor, dyskinesia, and ON-OFF assessments. Mov Disord (2008) 0.92
Novel syngeneic pseudo-orthotopic prostate cancer model: vascular, mitotic and apoptotic responses to castration. Microvasc Res (2005) 0.91
Identification of class I HLA T cell control epitopes for West Nile virus. PLoS One (2013) 0.91
HLA alleles and haplotypes among the Lakota Sioux: report of the ASHI minority workshops, part III. Hum Immunol (2004) 0.91
The immune response under stress: the role of HSP-derived peptides. Trends Immunol (2004) 0.91
Dendritic cell vaccination against ovarian cancer--tipping the Treg/TH17 balance to therapeutic advantage? Expert Opin Biol Ther (2011) 0.90
Implications of aging and self-tolerance on the generation of immune and antitumor immune responses. Cancer Res (2008) 0.90
Infection, replication, and cytopathology of human papillomavirus type 31 in trophoblasts. Virology (2003) 0.89
Rhesus macaque MHC class I molecules present HLA-B-like peptides. J Immunol (2005) 0.89
Calcitonin increases invasiveness of prostate cancer cells: role for cyclic AMP-dependent protein kinase A in calcitonin action. Int J Cancer (2005) 0.89
Immunity, cancer and aging: lessons from mouse models. Aging Dis (2011) 0.89
Analysis of the results of sleeve gastrectomy for morbid obesity and the role of ghrelin. Surg Today (2008) 0.89
Geometry of human vascular system: is it an obstacle for quantifying antiangiogenic therapies? Appl Immunohistochem Mol Morphol (2007) 0.89
Combined hepatocellular cholangiocarcinomas; analysis of a large database. Clin Med Pathol (2008) 0.88
CypD(-/-) hearts have altered levels of proteins involved in Krebs cycle, branch chain amino acid degradation and pyruvate metabolism. J Mol Cell Cardiol (2012) 0.88
TCR-like biomolecules target peptide/MHC Class I complexes on the surface of infected and cancerous cells. Int Rev Immunol (2011) 0.87
Development and implementation of a direct detection, quantitation and validation system for class I MHC self-peptide epitopes. J Immunol Methods (2006) 0.87
Immunolocalization of sperm protein 17 in human testis and ejaculated spermatozoa. J Histochem Cytochem (2003) 0.87
Surface phenotype and functionality of WNV specific T cells differ with age and disease severity. PLoS One (2010) 0.87
Comparative kinetic analyses of gene profiles of naïve CD4+ and CD8+ T cells from young and old animals reveal novel age-related alterations. Aging Cell (2011) 0.87
Amyloid precursor-like protein 2 association with HLA class I molecules. Cancer Immunol Immunother (2009) 0.86
Galectin-3C inhibits tumor growth and increases the anticancer activity of bortezomib in a murine model of human multiple myeloma. PLoS One (2011) 0.86
Proteome sampling by the HLA class I antigen processing pathway. PLoS Comput Biol (2012) 0.85
Calcitonin receptor-stimulated migration of prostate cancer cells is mediated by urokinase receptor-integrin signaling. Clin Exp Metastasis (2007) 0.85
Targeting the tumor microenvironment with anti-neu/anti-CD40 conjugated nanoparticles for the induction of antitumor immune responses. Vaccine (2009) 0.85
The role of MHC class I allele Mamu-A*07 during SIV(mac)239 infection. Immunogenetics (2011) 0.85
Notch-ing from T-cell to B-cell lymphoid malignancies. Cancer Lett (2011) 0.85
Cooperative effect between immunotherapy and antiangiogenic therapy leads to effective tumor rejection in tolerant Her-2/neu mice. Cancer Res (2003) 0.85
Impact of aging on cancer immunity and immunotherapy. Cancer Immunol Immunother (2009) 0.85
Cancer initiation and progression: an unsimplifiable complexity. Theor Biol Med Model (2006) 0.84
Assessing vaccine potency using TCRmimic antibodies. Vaccine (2008) 0.84
Cancer testes antigens in breast cancer: biological role, regulation, and therapeutic applicability. Int Rev Immunol (2012) 0.84
Although divergent in residues of the peptide binding site, conserved chimpanzee Patr-AL and polymorphic human HLA-A*02 have overlapping peptide-binding repertoires. J Immunol (2011) 0.84
The multiple faces of glucagon-like peptide-1--obesity, appetite, and stress: what is next? A review. Dig Dis Sci (2007) 0.84
Is sperm protein 17 a useful target for tumor immunotherapy? Blood (2003) 0.84
Modulation of the in vivo primate anti-Gal response through administration of anti-idiotypic antibodies. Xenotransplantation (2002) 0.83
Mast cells and human hepatocellular carcinoma. World J Gastroenterol (2003) 0.83
Tracking human multiple myeloma xenografts in NOD-Rag-1/IL-2 receptor gamma chain-null mice with the novel biomarker AKAP-4. BMC Cancer (2011) 0.83
Direct discovery and validation of a peptide/MHC epitope expressed in primary human breast cancer cells using a TCRm monoclonal antibody with profound antitumor properties. Cancer Immunol Immunother (2009) 0.83
Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy. Int Rev Immunol (2015) 0.83